Clik here to view.
Stryker closes $1.3B Physio-Control deal
Stryker (NYSE:SYK) said today that it closed the $1.28 billion acquisition of automated external defibrillator maker Physio-Control from Bain Capital. Medtronic (NYSE:MDT) sold Physio-Control to Bain...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for April 5, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Bracco wins FDA nod for liver cancer microspheres
Bracco Diagnostics said yesterday it won FDA premarket approval for its Lumason ultrasound imaging agent, now indicated for use in ultrasonography of the liver for characterization of focal liver...
View ArticleClik here to view.
Study: Proteus Discover boosts compliance, lowers BP & LDL | ACC 2016
Proteus Digital Health yesterday presented interim results from a study of its Proteus Discover for patients with uncontrolled hypertension and type 2 diabetes, claiming use of the system raised...
View ArticleClik here to view.
EnteroMedics touts study showing improved weight loss in moderate obesity...
EnteroMedics (NSDQ:ETRM) today released data from the ReCharge study of its vBloc Neurometabolic Therapy in patients with moderate obesity, touting 74% greater weight loss with vBloc therapy compared...
View ArticleClik here to view.
FDA, NIH propose new clinical trial protocol template for investigational...
By Stewart Eisenhart, Emergo Group The US Food and Drug Administration and the National Institutes of Health (NIH) have jointly proposed a new template for clinical trial sponsors to use for submitting...
View ArticleClik here to view.
Medtronic still unfazed by new inversion rules
Medtronic (NYSE:MDT) remains unfazed by the U.S. Treasury Dept.’s push to rein in so-called “inversion” mergers, which allow American companies to re-organized under foreign jurisdictions, after the...
View ArticleClik here to view.
SurModics launches 1st-in-human trial for SurVeil drug-coated balloon
SurModics (NSDQ:SRDX) said it enrolled the 1st patient in an early feasibility trial of its SurVeil drug-coated balloon for treating peripheral artery disease, as it looks to metamorphose from device...
View ArticleClik here to view.
Edap seeks FDA nod for Focal One HIFU
Edap (NSDQ:EDAP) said today it submitted an application for FDA 510(k) clearance for its next-gen high-intensity focused ultrasound Focal One device designed to treat prostate cancer. The company said...
View ArticleClik here to view.
MC10 inks Japanese distro deal with Marubun for BioStamp
MC10 said today it inked a limited exclusive distribution partnership with Marubun Corp. to distribute its BioStamp products in Japan. The Lexington, Mass.-based company’s BioStamp sensor products are...
View ArticleClik here to view.
Amid public feuds, NEJM finds itself under attack
by Charles Ornstein, ProPublica. The New England Journal of Medicine is arguably the best-known and most venerated medical journal in the world. Studies featured in its pages are cited more often, on...
View ArticleClik here to view.
FDA releases March 2016 510(k) clearances
510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD March 2016 TOTAL 510(k)s THIS PERIOD 279 TOTAL WITH SUMMARIES 265 TOTAL WITH STATEMENTS 14 DEVICE: QuikRead go CRP,...
View ArticleClik here to view.
Cadence expands cleanroom capabilities
Cadence announced today plans to enhance cleanroom capabilities in its Plymouth, Mass., and Santo Domingo, Dominican Republic-based facilities to expand support for medical device and life science...
View ArticleClik here to view.
Eximo Medical’s hybrid catheter clears pivotal trial
Eximo Medical said a 20-patient pivotal trial in Europe, aimed at winning CE Mark approval there for its hybrid peripheral catheter, met its safety and efficacy endpoints. Rehovot, Israel-based Eximo’s...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for April 6, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
PathMaker and Feinstein Inst launch MyoRegulator spasticity trial
PathMaker Neurosystems said today it paired with the Feinstein Institute and Northwell Health to launch an IRB-approved clinical trial of its MyoRegulator device designed to treat muscle spasticity....
View ArticleClik here to view.
InVivo adds 19th site at University of Virginia site to Inspire study
InVivo Therapeutics (NSDQ:NVIV) is continuing to add sites to the Inspire study of its NeuroSpinal Scaffold, announcing today that it added a new site at the Charlottesville’s University of Virginia...
View ArticleClik here to view.
Advanced Brain Monitoring wins FDA nod for Sleep Profiler PSG2
Sleep and neurological disorder device developer Advanced Brain Monitoring said today it won FDA 510(k) clearance for its Sleep Profiler PSG2 overnight EEG designed for to diagnose sleep apnea. The...
View ArticleClik here to view.
FDA clears Medtronic’s miniature Micra transcatheter pacer
Medtronic (NYSE:MDT) said today it won FDA premarket approval for its Micra transcatheter pacing system, which it claims is the world’s smallest pacemaker. The Micra transcatheter pacing system, which...
View ArticleClik here to view.
Johnson & Johnson’s $5m mesh settlement could push costs higher
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon could be facing a steeper-than-expected tab when it comes to settling the more than 46,000 product liability lawsuits brought over its pelvic mesh...
View Article